EC-SOD gene therapy reduces paracetamol-induced liver damage in mice

J Gene Med. 2001 Jul-Aug;3(4):321-5. doi: 10.1002/jgm.194.

Abstract

Background: Paracetamol overdose causes acute liver damage which leads to severe centrilobular hepatic necrosis. The hepatotoxic effect is caused by reactive metabolites and oxidative stress. Since extracellular superoxide dismutase (EC-SOD) protects tissues against the harmful effects of superoxide anion, the hypothesis that systemic adenovirus-mediated EC-SOD gene transfer could reduce liver damage was tested.

Methods: Mice were given paracetamol (600 mg/kg) enterally 2 days after adenovirus-mediated gene transfer of EC-SOD (2 x 10(9) pfu). Five days after gene transfer, plasma and tissue samples were collected for clinical chemistry analyses and tissue pathology evaluation.

Results: EC-SOD was expressed in a dose-dependent manner with the highest enzyme activity occurring 3 days after the gene transfer. Clinical chemistry and tissue pathology analyses showed that adenoviral EC-SOD gene transfer significantly attenuated release of liver enzymes and inhibited necrosis and apoptosis caused by paracetamol overdose.

Conclusion: The results indicate the involvement of superoxide anion in paracetamol-mediated liver damage and suggest a possible protective role for EC-SOD gene transfer in paracetamol-induced liver damage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetaminophen / toxicity*
  • Animals
  • Caspase 3
  • Caspases / metabolism
  • Genetic Therapy / methods*
  • Hepatitis, Animal / chemically induced*
  • Hepatitis, Animal / pathology
  • Hepatitis, Animal / therapy
  • Kinetics
  • Liver / drug effects
  • Liver / pathology*
  • Mice
  • Recombinant Proteins / pharmacology
  • Superoxide Dismutase / genetics*
  • Superoxide Dismutase / pharmacology
  • Time Factors

Substances

  • Recombinant Proteins
  • Acetaminophen
  • Superoxide Dismutase
  • Casp3 protein, mouse
  • Caspase 3
  • Caspases